Drugmaker Pfizer's CEO Read to Leave in January

U.S. News 

The New York company said in July that it was reshaping its business into three units: Innovative Medicines; Established Medicines, which handles older drugs that have lost protection; and Consumer Healthcare. It said Innovative Medicines will bring in most of the company's revenue and has strong growth potential due partially to an aging population that will create growing demand for new medicines.

Duplicate Docs Excel Report

None found

Similar Docs  Excel Report  more

None found